Biologic Therapy Market Research Report- Global Forecast to 2023

Biologic Therapy Market Research Report- Global Forecast to 2023

ID: MRFR/LS/0344-HCRR | | Region: Global | 105 pages | Half-Cooked Research Reports

Global Biologic Therapy Market Information: By Product Type (Kits and Reagents, Services), by Therapy (Protein Therapy, Vaccines Therapy), by Application (Cellular and Gene Therapy), and by End-User (Hospitals and Clinics and Specialty Centers) – Global Forecast Till 2023


Market Scenario


Biologic therapy is a treatment that uses products made from living organisms to treat diseases. Some of the biologic therapies stimulate or suppress the immune system to help the body fight chronic diseases such as cancer, infection, and certain other diseases.


The biologic therapy market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the global biologic therapy market. 


Factors that are likely to hamper the growth of the market are adverse effects of drug therapy, stringent government regulations, and the high cost of drug development.


Global Biologic Therapy Market is expected to grow at a CAGR of 6.1% during the forecast period.


 Biologic Therapy Market


Figure: Global Biologic Therapy Market, by Region, 2016 (%)


 Source: World Health Organization, Centers for Disease Control and Prevention, Expert Interview, Annual Report, White Paper, Company Presentation, and Market Research Future Analysis


Intended Audience



  • Pharmaceutical Manufacturers and Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology:


 Biologic Therapy Research Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, Expert Interview, Annual Report, White Paper, Company Presentation, and Market Research Future Analysis


Segments                                                                                                                                            


The global biologic therapy market is segmented on the basis of product type, therapy, application, and end-user.


On the basis of product type, the market is segmented into kits and reagents, services, and instruments.


On the basis of therapy, the market is segmented into protein therapy, vaccines therapy, cell therapy, and others.


On the basis of application, the market is segmented into vaccine and therapeutics development, blood and blood-related products testing, cellular and gene therapy, tissue and tissue-related products testing, and stem cell research.


On the basis of end-user, the market is segmented into specialty centers, research centers, and hospitals and clinics.


Regional Analysis


The North American biologic therapy market is a growing market in the Americas region. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing aging population leading to rising in patient population and rising prevalence of cancer are likely to enhance the growth of the biologic therapy market in the North American region. Additionally, heavy research and development in the biologic therapy sector, increasing number of health insurance coverage for serious diseases, growth in companies offering technologically advanced products to the customers, and growing government initiative are pushing the growth of the market. For instance, according to the United States Census Bureau, around 49.2 million adults aged 65 and above were present in the U.S. as of 2016. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S. Similarly, the increasing expenditure by the government for research and development is likely to propel the growth of the market. For instance, NIH received USD 1 Billion, in the year 2015 for life science and health-related research and development programs.


Europe is the second largest market and holds a noticeable share in the global biologic therapy market. The European market is expected to grow during the forecast period owing to the availability of innovative and advanced treatment facilities and rising skilled medical professionals. Furthermore, growing older population, giving rise to patient population is likely to enhance the growth of the market. For instance, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above. This rising older population is likely to lead to an increase in patient population.


Asia Pacific is expected to be the fastest growing market due to the increasing prevalence of cancer and other lifestyle-induced disorders. China is the fastest growing region owing to its large older population and increasing patient population. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure, growing standard of living, and the overall growth of the healthcare industry also drive the market.


The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and affordability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market owing to the development of healthcare infrastructure and rising skilled medical professionals.


Key Players                                                                                                         


Some of the players in the biologic therapy market are GlaxoSmithKline Plc., Bristol-Myers Squibb, Celgene Corporation, Amgen Inc., Novartis International AG, Eli Lilly, Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., etc.

Table of Content



1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis



6. Global Biologic Therapy Market, by Product Type

6.1 Introduction

6.2 Kits & Reagents

6.2.1 Market Estimates & Forecast, 2017–2023

6.3 Services

6.3.1 Market Estimates & Forecast, 2017–2023

6.4 Instruments

6.4.1 Market Estimates & Forecast, 2017–2023



7. Global Biologic Therapy Market, by Therapy

7.1 Introduction

7.2 Protein Therapy

7.2.1 Market Estimates & Forecast, 2017–2023

7.3 Vaccines Therapy

7.3.1 Market Estimates & Forecast, 2017–2023

7.4 Cell Therapy

7.4.1 Market Estimates & Forecast, 2017–2023

7.5 Others

7.5.1 Market Estimates & Forecast, 2017–2023

8. Global Biologic Therapy Market, by Application

8.1 Introduction

8.2 Vaccine & Therapeutics Development

8.2.1 Market Estimates & Forecast, 2017–2023

8.3 Blood and Blood-Related Products Testing

8.3.1 Market Estimates & Forecast, 2017–2023

8.4 Cellular and Gene Therapy

8.4.1 Market Estimates & Forecast, 2017–2023

8.4 Tissue and Tissue-Related Products Testing

8.4.1 Market Estimates & Forecast, 2017–2023

8.4 Stem Cell Research

8.4.1 Market Estimates & Forecast, 2017–2023





9. Global Biologic Therapy Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2017–2023

9.3 Specialty Centers

9.3.1 Market Estimates & Forecast, 2017–2023

9.4 Research Centers

9.4.1 Market Estimates & Forecast, 2017–2023



10 Global Biologic Therapy Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K.

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Amgen Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Bristol-Myers Squibb

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Celgene Corporation

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 F. Hoffmann-La Roche AG

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Novartis International AG

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 GlaxoSmithKline Plc

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Seattle Genetics, Inc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix



LIST OF TABLES



Table 1 Prescribed Biologic Therapy Industry Synopsis, 2017–2023

Table 2 Global Biologic Therapy Market Estimates and Forecast, 2017–2023, (USD Million)

Table 3 Global Biologic Therapy Market, by Region, 2017–2023, (USD Million)

Table 5 Global Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 6 Global Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 7 Global Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 8 North America Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 9 North America Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 10 North America Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 11 US Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 12 US Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 13 US Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 14 Canada Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 15 Canada Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 16 Canada Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 17 South America Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 18 South America Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 19 South America Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 20 Europe Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 21 Europe Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 22 Europe Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 23 Western Europe Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 24 Western Europe Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 25 Western Europe Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 26 Eastern Europe Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 27 Eastern Europe Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 28 Eastern Europe Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 29 Asia Pacific Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 30 Asia Pacific Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 31 Asia Pacific Biologic Therapy Market, by End-User, 2017–2023, (USD Million)

Table 32 Middle East & Africa Biologic Therapy Market, by Type, 2017–2023, (USD Million)

Table 33 Middle East & Africa Biologic Therapy Market, by Application, 2017–2023, (USD Million)

Table 34 Middle East & Africa Biologic Therapy Market, by End-User, 2017–2023, (USD Million)



LIST OF FIGURES



Figure 1 Research Process

Figure 2 Segmentation for Global Biologic Therapy Market

Figure 3 Segmentation Market Dynamics for Biologic Therapy Market

Figure 4 Global Biologic Therapy Market Share, by Type 2016

Figure 5 Global Biologic Therapy Market Share, by Application 2016

Figure 6 Global Biologic Therapy Market Share, by End-User, 2016

Figure 7 Global Biologic Therapy Market Share, by Region, 2016

Figure 8 North America Biologic Therapy Market Share, by Country, 2016

Figure 9 Europe Biologic Therapy Market Share, by Country, 2016

Figure 10 Asia Pacific Biologic Therapy Market Share, by Country, 2016

Figure 11 Middle East & Africa Biologic Therapy Market Share, by Country, 2016

Figure 12 Global Biologic Therapy Market: Company Share Analysis, 2016 (%)

Figure 13 Amgen Inc.: Key Financials

Figure 14 Amgen Inc.: Segmental Revenue

Figure 16 Amgen Inc.: Geographical Revenue

Figure 17 Celgene Corporation: Key Financials

Figure 18 Celgene Corporation: Segmental Revenue

Figure 19 Celgene Corporation: Geographical Revenue

Figure 20 Novartis International AG: Key Financials

Figure 21 Novartis International AG Segmental Revenue

Figure 22 Novartis International AG: Geographical Revenue

Figure 23 Seattle Genetics, Inc.: Key Financials

Figure 24 Seattle Genetics, Inc.: Segmental Revenue

Figure 25 Seattle Genetics, Inc.: Geographical Revenue

Figure 26 Spectrum Pharmaceuticals, Inc.: Key Financials

Figure 27 Spectrum Pharmaceuticals, Inc.: Segmental Revenue

Figure 28 Spectrum Pharmaceuticals, Inc.: Geographical Revenue

Figure 29 GlaxoSmithKline Plc. Key Financials

Figure 30 GlaxoSmithKline Plc. Segmental Revenue

Figure 31 GlaxoSmithKline Plc. Geographical Revenue

Figure 32 Stryker: Key Financials

Figure 33 Stryker: Segmental Revenue

Figure 34 Stryker: Geographical Revenue